Page last updated: 2024-08-21

quinazolines and vadimezan

quinazolines has been researched along with vadimezan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Döme, B; Magyar, M	1
Lenihan, DJ; Subbiah, IM; Tsimberidou, AM	1

Reviews

1 review(s) available for quinazolines and vadimezan

Article	Year
[Tumor vasculature as a therapeutic target in non-small cell lung cancer]. Magyar onkologia, 2008, Volume: 52, Issue:3 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Axitinib; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Humans; Imidazoles; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sulfonamides; Xanthones	2008

Article

Year

[Tumor vasculature as a therapeutic target in non-small cell lung cancer].

Magyar onkologia, 2008, Volume: 52, Issue:3

Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Axitinib; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Humans; Imidazoles; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sulfonamides; Xanthones

2008

Other Studies

1 other study(ies) available for quinazolines and vadimezan

Article	Year
Cardiovascular toxicity profiles of vascular-disrupting agents. The oncologist, 2011, Volume: 16, Issue:8 Topics: Angiogenesis Inhibitors; Bibenzyls; Cardiovascular System; Clinical Trials as Topic; Humans; Neoplasms; Neovascularization, Pathologic; Organophosphorus Compounds; Quinazolines; Serine; Xanthones	2011